Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil Augmentation in Chronic Schizophrenia
NCT00838227Phase 2Withdrawn
- Sponsor
- Manhattan Psychiatric Center
- Start
- Feb 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of modafinil in schizophrenia, sponsored by Manhattan Psychiatric Center. Planned start Feb 2008; status: withdrawn.
02
Drugs
modafinil
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00838227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838227.